Skip to content

Interference by Activated Protein C Resistance in the Determination of Protein S Activity

Interference by Activated Protein C Resistance in the Determination of Protein S Activity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06182501
Acronym
PS
Enrollment
9470
Registered
2023-12-27
Start date
2022-07-01
Completion date
2023-12-31
Last updated
2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistance to Activated Protein C in the Determination of Protein S Activity

Keywords

protein C, protein S, activated protein C

Brief summary

Protein S is an anticoagulant protein and a cofactor of protein C. It is recommended to explore it first by a functional (chronometric) technique by assessing its cofactor activity of activated protein C. Existing tests measure the prolongation of a coagulation time. These tests are all dependent on factor V, but some patients have mutations in factor V (including V Leiden) that make them resistant to activated protein C activity. It is suspected that these mutations lead to underestimations of protein S activity by chronometric technique.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient of legal age (≥ 18 years) * Patient for whom a sample has been sent to the HUS Hematology Laboratory for measurement of protein S activity between 28/12/2009 and 29/12/2020 * Patient who does not object to the reuse of his/her medical data for scientific research purposes.

Exclusion criteria

* Minor patient * Patient with incomplete data

Design outcomes

Primary

MeasureTime frame
Functional test protein C resistanceThrough study completion, an average of 2 months

Countries

France

Contacts

Primary ContactAgathe HERB, MD, PhD
agathe.herb@chru-strasbourg.fr33 3 88 12 75 53

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026